# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-106463
Filing Date
2023-04-19
Accepted
2023-04-19 16:12:57
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d468881ddefa14a.htm | DEFA14A | 28125
2 | GRAPHIC | g468881dsp001.jpg | GRAPHIC | 255308
3 | GRAPHIC | g468881dsp002.jpg | GRAPHIC | 218249
4 | GRAPHIC | g468881g00c01.jpg | GRAPHIC | 405816
5 | GRAPHIC | g468881g00c02.jpg | GRAPHIC | 256540
6 | GRAPHIC | g468881image001.jpg | GRAPHIC | 5856
| Complete submission text file | 0001193125-23-106463.txt |  | 1600352

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 23830173
SIC: 2834 Pharmaceutical Preparations